Entero Therapeutics Inc.

0.51
-0.04 (-6.59%)
At close: Jan 22, 2025, 3:59 PM
0.51
-0.20%
After-hours Jan 22, 2025, 04:00 PM EST

Entero Therapeutics Statistics

Share Statistics

Entero Therapeutics has 4.75M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding 4.75M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Institutions (%) n/a
Shares Floating -
Failed to Deliver (FTD) Shares 3.17K
FTD / Avg. Volume 1.51%

Short Selling Information

The latest short interest is 94.02K, so 1.98% of the outstanding shares have been sold short.

Short Interest 94.02K
Short % of Shares Out 1.98%
Short % of Float 2.02%
Short Ratio (days to cover) 0.12

Valuation Ratios

The PE ratio is -0.08 and the forward PE ratio is -0.41.

PE Ratio -0.08
Forward PE -0.41
PS Ratio 0
Forward PS 0.1
PB Ratio 0.36
P/FCF Ratio -0.1
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Entero Therapeutics Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.23.

Current Ratio 1.58
Quick Ratio 1.58
Debt / Equity 0.23
Total Debt / Capitalization 18.67
Cash Flow / Debt -14.97
Interest Coverage -702.08

Financial Efficiency

Return on equity (ROE) is -4.38% and return on capital (ROIC) is -356.02%.

Return on Equity (ROE) -4.38%
Return on Assets (ROA) -2.29%
Return on Capital (ROIC) -356.02%
Revenue Per Employee 0
Profits Per Employee -1.75M
Employee Count 9
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -85.83% in the last 52 weeks. The beta is 1.22, so Entero Therapeutics 's price volatility has been higher than the market average.

Beta 1.22
52-Week Price Change -85.83%
50-Day Moving Average 0.58
200-Day Moving Average 1.21
Relative Strength Index (RSI) 44.62
Average Volume (20 Days) 209.73K

Income Statement

Revenue n/a
Gross Profit -29.27K
Operating Income -15.77M
Net Income -15.79M
EBITDA -15.74M
EBIT n/a
Earnings Per Share (EPS) -47.88
Full Income Statement

Balance Sheet

The company has 3.71M in cash and 826.84K in debt, giving a net cash position of 2.88M.

Cash & Cash Equivalents 3.71M
Total Debt 826.84K
Net Cash 2.88M
Retained Earnings -184.33M
Total Assets 85.82M
Working Capital 68.15M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.38M and capital expenditures -500.00K, giving a free cash flow of -12.88M.

Operating Cash Flow -12.38M
Capital Expenditures -500.00K
Free Cash Flow -12.88M
FCF Per Share -38.29
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ENTO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -9388.24%
FCF Yield -526.19%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ENTO.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Dec 18, 2023. It was a backward split with a ratio of 1:20.

Last Split Date Dec 18, 2023
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score -2.77
Piotroski F-Score 1